Goals for New Antiviral Therapies for Chronic Hepatitis B
Safe and well-tolerated for long term use
Effective in all patient populations
- HBeAg+ and HBeAg–
- HBV genotypes (A-G)
- Compensated and decompensated liver disease
- Post-liver transplantation
- Drug resistant virus
High threshold for the development of resistance